Breaking News, Collaborations & Alliances

Tonix and Fujifilm Enter COVID-19 Vax Deal

Collaboration includes development of manufacturing processes and supply of clinical trial material to support Tonix’s development of TNX-1800

By: Contract Pharma

Contract Pharma Staff

Tonix Pharmaceuticals, a clinical-stage biopharma, has entered an agreement with Fujifilm Diosynth Biotechnologies (FDB), which will provide contract manufacturing and development services to support the manufacturing of Tonix’s COVID-19 vaccine candidate, TNX-1800, for clinical trial supply.   “Tonix is proud to partner with Fujifilm Diosynth Biotechnologies, a leader in pharmaceutical manufacturing and development,” said Seth Lederman, president and chief executive officer, Tonix. “Live replic...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters